Contact
searchSearch
HMP Global

Office-Based Labs (OBL) Corner

Features

MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Craig Walker, MD
Video Commentary
Optimizing Safety and Outcomes in Outpatient Practice
01/19/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker...
01/19/2026
Vascular Disease Management
Clinical Editor's Corner
Ensuring Safety and Effectiveness in Outpatient Settings
01/16/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article...
01/16/2026
Vascular Disease Management
Review
Safety in Office-Based Laboratories and Ambulatory Surgery Centers
01/15/2026
Krishna Jain, MD, FACS
The author summarizes evidence that endovascular procedures in OBLs and ASCs achieve safety outcomes comparable to hospitals when standardized policies and compliance are in place.
The author summarizes evidence that endovascular procedures in OBLs and ASCs achieve safety outcomes comparable to hospitals when standardized policies and compliance are in place.
The author summarizes evidence...
01/15/2026
Vascular Disease Management
Bret Wiechmann, MD
OBL Corner
Is There an Optimal Site of Service for CLTI Intervention: Hospital, ASC, or OBL?
09/04/2025
Bret N. Wiechmann, MD, FSIR, FAHA; Mike Watts, MD, FSIR
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike...
09/04/2025
Vascular Disease Management
OBL Corner
OBL Spotlight: Joint & Vascular Institute
08/22/2025
Osman Ahmed, MD
VDM spoke with interventional radiologist Osman Ahmed, MD, FSIR, FCIRSE, about the Joint & Vascular Institute, a new OBL in Libertyville, Illinois, that he started with Mikin V. Patel, MD, MBA.
VDM spoke with interventional radiologist Osman Ahmed, MD, FSIR, FCIRSE, about the Joint & Vascular Institute, a new OBL in Libertyville, Illinois, that he started with Mikin V. Patel, MD, MBA.
VDM spoke with interventional...
08/22/2025
Vascular Disease Management
Teri Yates
AMP 2025
The Pros and Cons of OBLs and ASCs
08/15/2025
Teri Yates
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable...
08/15/2025
Vascular Disease Management
Dr Foster
AMP 2025
Novel Radiation Shielding Device Shows Dramatic Drops in Operator Radiation in an OBL Setting
08/14/2025
Robert Foster, MD
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a...
08/14/2025
Vascular Disease Management
Drug-Coated Balloons
Cardiovascular Institute of the South Is First in the World to Use New Drug-Coated Balloon to Treat Leg Artery Blockages
05/27/2025
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette,...
05/27/2025
Vascular Disease Management

Videos & Podcasts

Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Craig Walker, MD
Video Commentary
Optimizing Safety and Outcomes in Outpatient Practice
01/19/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker...
01/19/2026
Vascular Disease Management
Bret Wiechmann, MD
OBL Corner
Is There an Optimal Site of Service for CLTI Intervention: Hospital, ASC, or OBL?
09/04/2025
Bret N. Wiechmann, MD, FSIR, FAHA; Mike Watts, MD, FSIR
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike...
09/04/2025
Vascular Disease Management
Dr Tummala
OBL Corner
Pre- and Post-Intervention Arterial Evaluation in the OBL
04/03/2025
Srini Tummala, MD
In this video, interventional radiologist Srini Tummala, MD, discusses the presentation he gave at ISET 2025 on the importance of pre- and post-intervention arterial evaluation in the office-based lab setting. 
In this video, interventional radiologist Srini Tummala, MD, discusses the presentation he gave at ISET 2025 on the importance of pre- and post-intervention arterial evaluation in the office-based lab setting. 
In this video, interventional...
04/03/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Dr Bret Wiechmann
AMP 2024
OEIS National Registry: An Update on CLI Patients and Complications
09/18/2024
Bret N. Wiechmann, MD, FSIR, FAHA
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann discusses his AMP 2024 presentation on the latest updates to the OEIS Registry.
Watch as Dr. Bret Wiechmann...
09/18/2024
Vascular Disease Management
Dr. Raja
AMP 2023
Benefits of Running an Office-Based Lab
11/15/2023
M. Laiq Raja, MD, FACC, FSCAI
In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.
In this video, Interventional Cardiologist Dr. Laiq Raja discusses the benefits of an office-based lab, for both physicians and patients.
In this video, Interventional...
11/15/2023
Vascular Disease Management
Chris LeSar, MD
AMP 2023
Inspiration to Open an Office-Based Lab
11/15/2023
Chris LeSar, MD, FACS, RVT
Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.
Dr. Chris LeSar talks about the driving forces that led him to open his own office-based lab.
Dr. Chris LeSar talks about the...
11/15/2023
Vascular Disease Management
Drs. Wiechmann, Davis, and Secemsky
Vascular Voices Podcast
Using Atherectomy to Treat CLI and Why OBLs Are Needed
10/18/2023
In this episode, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why OBLs are needed in the vascular space. 
In this episode, join Drs. Bret Wiechmann, Thomas Davis, and Eric Secemsky as they discuss the current debate about using atherectomy to treat patients with critical limb ischemia and why OBLs are needed in the vascular space. 
In this episode, join Drs. Bret...
10/18/2023
Vascular Disease Management
Drs Wiechmann and Saab
Vascular Voices Podcast
How the Outpatient Endovascular and Interventional Society Can Help Improve Office-Based Labs
07/25/2023
Bret N. Wiechmann, MD, FSIR, FAHA; Fadi Saab, MD, FACC, FSCAI
In this episode, Dr Bret Wiechmann, interventional radiologist and president of the OEIS joins Dr Fadi Saab, interventional cardiologist, to talk about the OEIS and the important role it plays in improving outpatient practice.
In this episode, Dr Bret Wiechmann, interventional radiologist and president of the OEIS joins Dr Fadi Saab, interventional cardiologist, to talk about the OEIS and the important role it plays in improving outpatient practice.
In this episode, Dr Bret...
07/25/2023
Vascular Disease Management
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
05/01/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
05/01/2026
Vascular Disease Management
Drs Gray, Salazar, and Rosenfield speak at ISET 2026
Sponsored Video
What Matters Most in Enhanced Radiation Protection: Occupational Wellness in the Lab With Salus Scientific
04/20/2026
Kenneth Rosenfield, MD, MSc; William A. Gray, MD, FACC, FSCAI; Gloria Salazar, MD, FSIR
Join us as Dr Kenny Rosenfield moderates a session on what matters most in enhanced radiation protection device (ERPD) technology today.
Join us as Dr Kenny Rosenfield moderates a session on what matters most in enhanced radiation protection device (ERPD) technology today.
Join us as Dr Kenny Rosenfield...
04/20/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Surmodics Video Presentation
Sponsored VIdeo
#POUNCEIT! Watch Now: AMP Symposium Videos
03/26/2026
Fadi Saab, MD, FACC, FSCAI; Mahmood Razavi, MD; Lucas Ferrer Cardona, MD; Miguel Montero-Baker, MD; Dean Ferrera, DO; Stylianos Papadakos, MD
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention...
03/26/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management

Presentations

Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Teri Yates
AMP 2025
The Pros and Cons of OBLs and ASCs
08/15/2025
Teri Yates
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable...
08/15/2025
Vascular Disease Management
Dr Foster
AMP 2025
Novel Radiation Shielding Device Shows Dramatic Drops in Operator Radiation in an OBL Setting
08/14/2025
Robert Foster, MD
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a...
08/14/2025
Vascular Disease Management
Dr Laiq Raja
AMP 2024
How to Manage Complex CLI Patients With Wounds in an Outpatient Program
08/14/2024
M. Laiq Raja, MD, FACC, FSCAI
Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex CLI)patients with wounds in an outpatient program.
Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex CLI)patients with wounds in an outpatient program.
Laiq Raja, MD, FACC, FSCAI, from...
08/14/2024
Vascular Disease Management
Dr Wiechmann
AMP 2023
Why the OBL/ASC Is Critical in the Treatment of the CLI Patient
08/21/2023
Bret N. Wiechmann, MD, FSIR, FAHA
Interventional radiologist Dr Bret Wiechmann presented a discussion about the importance of office-based labs and ambulatory surgery centers when treating patients with critical limb ischemia.
Interventional radiologist Dr Bret Wiechmann presented a discussion about the importance of office-based labs and ambulatory surgery centers when treating patients with critical limb ischemia.
Interventional radiologist Dr...
08/21/2023
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Dr Elizabeth Genovese
ISET 2026
When Do I Think of a Bypass? Reframing Revascularization Decisions in CLTI
02/11/2026
Elizabeth Genovese, MD, MS, FACS, RPVI
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a nuanced question regarding patients with CLTI: when should bypass be considered first—and why?
Dr Elizabeth Genovese asked a...
02/11/2026
Vascular Disease Management
Dr William Kuo
ISET 2026
Clot Management in the IVC: Matching the Device to the Disease
02/11/2026
William T. Kuo, MD
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon session at ISET 2026, Sr William Kuo walked attendees through a practical, case-based approach to managing inferior vena cava thrombosis.
During a Wednesday afternoon...
02/11/2026
Vascular Disease Management
John Rundback MD
ISET 2026
Vessel Preparation for Tibial Interventions: Why “Just PTA” Is Rarely Enough
02/11/2026
John H. Rundback, MD, FAHA, FSIR
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges the long-standing notion that plain balloon angioplasty alone is sufficient for tibial interventions in patients with chronic limb-threatening ischemia .
Dr. John H. Rundback challenges...
02/11/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Sean P. Lyden, MD
ISET 2026
Real-World Acute Limb Ischemia: What the PROWL Registry Is Teaching Us
02/10/2026
Sean P. Lyden, MD
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new real-world data from the PROWL Registry, offering a look at how acute, subacute, and CLTI are being treated outside the confines of traditional clinical trial exclusions.
Sean P. Lyden, MD, discussed new...
02/10/2026
Vascular Disease Management
Dr Andrew Holden
ISET 2026
Bioresorbable Scaffolds in BTK Disease: Where We Are and Where We’re Headed
02/10/2026
Andrew Holden, MBChB
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Dr Andrew Holden delivered a...
02/10/2026
Vascular Disease Management
Ripal T. Gandhi, MD
ISET 2026
Single-Use Handheld Vascular Robotics: What Is the Future?
02/10/2026
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM, explored how single-use, handheld robotic systems could shape the next phase of peripheral endovascular intervention.
Ripal T. Gandhi, MD, FSIR, FSVM,...
02/10/2026
Vascular Disease Management
James F. Meschia, MD
ISET 2026
Redefining Optimal Medical Therapy in Carotid Disease: Key Lessons from CREST-2
02/09/2026
James F. Meschia, MD
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides an overview of what “optimal medical therapy” means in contemporary carotid disease management.
James F. Meschia, MD, provides...
02/09/2026
Vascular Disease Management
Nicos Labropoulos, MD
ISET 2026
Beyond Stenosis: Identifying the Truly High-Risk Carotid Plaque
02/09/2026
Nicos Labropoulos, MD
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented an overview of what defines a “high-risk” carotid plaque and why relying on luminal stenosis alone is no longer enough.
Nicos Labropoulos, MD, presented...
02/09/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Drug-Coated Balloons
Cardiovascular Institute of the South Is First in the World to Use New Drug-Coated Balloon to Treat Leg Artery Blockages
05/27/2025
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr....
May 24, 2024 – Lafayette,...
05/27/2025
Vascular Disease Management
News
American College of Surgeons and the Society for Vascular Surgery Release Standards for Outpatient Vascular Care
09/19/2023
CHICAGO (Sept. 19, 2023): The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has released new standards for outpatient vascular centers to help them provide optimal care and treatment of patients receiving...
CHICAGO (Sept. 19, 2023): The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has released new standards for outpatient vascular centers to help them provide optimal care and treatment of patients receiving...
CHICAGO (Sept. 19, 2023): The...
09/19/2023
Vascular Disease Management
News
Philips and BIOTRONIK Expand Care for Out-of-Hospital Cardiology Labs With New Strategic Alliance
06/27/2023

Philips Press Release

Philips Press Release
Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of...
Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of...
Alliance further strengthens...
06/27/2023
Vascular Disease Management
News
Dialysis Vascular Access Coalition (DVAC) Supports New Legislation to Stop Ongoing Cuts to Office-Based Specialists
06/15/2023
WASHINGTON, DC — Today, the Dialysis Vascular Access Coalition (DVAC) publicly supported the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas...
WASHINGTON, DC — Today, the Dialysis Vascular Access Coalition (DVAC) publicly supported the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674), introduced by Rep. Gus Bilirakis (R-FL-12), Rep. Tony Cardenas...
WASHINGTON, DC — Today, the...
06/15/2023
Cath Lab Digest
News
HST Pathways Announces Merger with Clariti Health for Enhanced Patient Price Transparency Resources as Part of its End-to-End Premium Technology Solution
06/01/2021
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST...
06/01/2021
Vascular Disease Management
News
Cardiovascular Institute of the South (CIS) Completes First Procedure in New Ambulatory Surgery Center
01/05/2021
Cardiovascular Institute of the South (CIS) completed the first outpatient procedure today in its new Ambulatory Surgery Center (ASC) located at 191 Innovation Ct, Ste B in Gray, La. The peripheral angiogram was performed by world-renowned...
Cardiovascular Institute of the South (CIS) completed the first outpatient procedure today in its new Ambulatory Surgery Center (ASC) located at 191 Innovation Ct, Ste B in Gray, La. The peripheral angiogram was performed by world-renowned...
Cardiovascular Institute of the...
01/05/2021
Vascular Disease Management
Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Pulmonary embolism
Thrombolex Announces Enrollment of 100th Patient in RAPID-PE Clinical Study
05/01/2026
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in...
05/01/2026
Vascular Disease Management
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Sirolimus-coated Balloons
Concept Medical Announces Preliminary 3-Year Sirona Data at Charing Cross Symposium 2026
04/28/2026
Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...
Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...
Preliminary 3-Year SIRONA Data...
04/28/2026
Vascular Disease Management
Bioresorbable Scaffolds
REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Critical Limb-Threatening Ischemia Patients
04/23/2026
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.
The MOTIV BTK trial met both its...
04/23/2026
Cath Lab Digest
BTK Intervention
Abbott Unveils Post-Approval Study Data Demonstrating Potential of Esprit BTK to Treat Significantly Sicker Patients with CLTI and Complex Lesions
04/21/2026
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the...
04/21/2026
Cath Lab Digest
Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Femoropopliteal Disease
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
04/21/2026
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif....
04/21/2026
Cath Lab Digest
Arteriovenous Fistula
Medtronic Reports Strong 12-Month Real-World Outcomes for IN.PACT™ AV Drug-Coated Balloon†
04/16/2026
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...
Post-approval study’s primary...
04/16/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use